(Q40718622)

23 September 2017

title

Oral poliomyelitis vaccine: time to change? (English)

1 reference

23 September 2017

1 reference

Swennen B

1

1 reference

23 September 2017

Levy J

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

23 September 2017

number of pages

6

1 reference

inferred from page(s)

published in

Vaccine

1 reference

23 September 2017

volume

19

1 reference

23 September 2017

issue

17-19

1 reference

23 September 2017

page(s)

2262-2267

1 reference

Effectiveness of Salk vaccine. Analysis of virologically confirmed cases of paralytic and nonparalytic poliomyelitis

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Paralytic poliomyelitis: seasoned strategies, disappearing disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Inactivated poliovirus vaccine: past and present experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Italy s new vaccination schedule reduced coverage of poliomyelitis vaccine in Naples

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

The World Health Organization's plan of action for global eradication of poliomyelitis by the year 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900549-1

7 January 2021

10.1016/S0264-410X(00)00549-1

Identifiers

DOI

1 reference

release_bymci7dcv5hfjd232jtg7dsp6y

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bymci7dcv5hfjd232jtg7dsp6y

24 November 2022

mapped directly with Wikidata item

1 reference